The Special Session of the General Assembly on the World Drug Problem (UNGASS 2016) will be convened from 19 – 21 April 2016 at United Nations Headquarters in New York. The UNGASS will feature a general debate plenary and five interactive, multi-stakeholder round tables conducted in parallel with the plenary.
A selection process is now open to identify speakers from civil society, the scientific community, academia, youth groups and other relevant stakeholders that may participate in the special session. Eleven (11) speakers will be selected: six (6) for the plenary and five (5) - one for each of the interactive round tables. Please note that travel funding is available for speakers chosen through this process. The final selection of speakers will be made by the Office of the President of the General Assembly, in collaboration with the Civil Society Task Force (CSTF) for UNGASS 2016. For more information on the CSTF, please click here.
The following criteria will be used when selecting speakers:
- Must represent an organization actively working in the drug field and be authorized to speak on behalf of that organization;
- Gender balance;
- Geographical balance and in the case of equal qualification, representatives from the Global South will be prioritised;
- Thematic balance in terms of approaches to drug policies;
- The call is open to representatives of ECOSOC and non-ECOSOC accredited NGOs.
In addition, selected representatives must:
- be able to speak compellingly within the context of an intergovernmental plenary or the respective round table;
- be available to be in New York on 19 April;
- have a visa for travel to New York, if applicable, or be able to obtain one within 4 weeks for travel to New York. The selected speakers will be responsible for obtaining the visa for travel and for any costs associated with obtaining the visa.
The deadline is the 7th of March.
To apply to speak at UNGASS 2016, please complete the form available here.
For more information about the special session, please visit the website.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.